IN VITRO ADME ASSAYS
Quick and cost-effective screening for your drug discovery.
In vitro ADME (Absorption, Distribution, Metabolism, and Excretion) assays are premier tools used to screen compounds at the early discovery stage. ADME studies can quickly and cost effectively screen out compounds with various liabilities. From liver microsome/hepatocyte assays that can be used to assess metabolic stabilities before in vivo screening to reaction phenotyping that can be used to understand metabolizing isozymes and assess polymorphism liabilities and MetID tools that can be used to locate soft spots on chemotypes to help chemistry teams quickly improve your compound’s in vivo half-life, PharmaLegacy has you covered.
At PharmaLegacy, we provide quality and efficient ADME screening assays for your drug discovery effort with a fast turnaround time.
Partition / Binding
Drug-Drug Interaction (DDI)
- 1,000+ validated animal models of disease spanning 40+ diseases
- FDA Part 11 compliant
- Rigorous adherence to international GLP and QA best practices
- PK/PD, molecular pharmacology and preliminary toxicology adjacency studies